Search the Newsreel

Intellect Design Arena expands pipeline to ₹13,000 Cr, clarifies Purple Fabric strategy

Genesis Minerals (ASX:GMD) Leads ASX Gold Stocks with Standout Session Surge

Pefindo Afirmasi Rating INPP di Level Single A Minus, Prospek: Stabil

ARMOUR Residential REIT (ARR) Returned To Profit, Is The Stock Still Cheap?

Uni-President China Delivers Profit Growth on Strong Food Sales and Margin Gains

Has Resideo Technologies (REZI) Stock Traded to a Discount After the Spin Off?

Track your investments for FREE with Simply Wall St, the portfolio command center trusted by over 7 million individual investors worldwide. Resideo Technologies stock has given shareholders a strong 66.6% return over the past three years, yet the latest checks suggest the share price …

Biodesix, Inc. (BDSX) Reports Q2 Loss, Beats Revenue Estimates

Biodesix, Inc. (BDSX) reported a Q2 loss of $0.71 per share, which beat the Zacks Consensus Estimate of a $0.86 loss, marking a 17.44% surprise. The company's revenues for the quarter reached $26.86 million, exceeding estimates by 2.92% and showing growth from $20.02 million …

Amit Mehta reports 46,434 Resideo Technologies, Inc. (REZI) shares held

Resideo Technologies, Inc.'s Senior Vice President Strategy and Business Operations, Amit Ashvin Mehta, has reported beneficial ownership of 46,434 shares of common stock. This information was disclosed in a Form 3 SEC filing as of August 3, 2026, indicating a direct holding without any …

Resideo Technologies (NYSE: REZI) SVP discloses holding of 168,192 shares

Joshua Peter Foster, Senior Vice President, General Counsel, and Corporate Secretary of Resideo Technologies (NYSE: REZI), has reported beneficial ownership of 168,192 shares of common stock. This disclosure was made via a Form 3 filing, indicating his initial statement of insider equity ownership. The …

BIODESIX ($BDSX) Releases Q2 2026 Earnings

Biodesix Inc (NASDAQ:BDSX) is scheduled to release its Q2 2026 earnings on August 5, 2026, with analysts expecting revenue of $26.03 million and earnings of -$0.91 per share. GuruFocus indicates a 6.22% upside based on its GF Value, while analysts have an average target …

Biodesix Diagnostic Testing Revenue Climbs 42% as Tests Reach 20,900

Biodesix reported strong Q2 2026 results, with total revenue increasing 34% to $26.9 million, driven by a 42% rise in Diagnostic Testing revenue. Test volumes grew by 38% to 20,900, contributing to an 82% gross margin. Despite a net loss of $7.3 million, the …

Biodesix (Nasdaq: BDSX) grows Q2 2026 revenue 34% to $26.9M

Biodesix (Nasdaq: BDSX) reported a 34% year-over-year revenue increase in Q2 2026, reaching $26.9 million, driven by a 42% rise in Diagnostic Testing revenue. Despite this growth and an improved gross margin of 82%, the company still reported a net loss of $7.3 million …

BIODESIX Inc Q2 2026: Revenue $26.86M, EPS $(0.71) — 10-Q Summary

BIODESIX Inc (BDSX) reported its Q2 2026 results, showing a 34% year-over-year revenue increase to $26.86 million and a narrowed net loss of $7.27 million, or $(0.71) per share, compared to $(1.56) in Q2 2025. The company's diagnostic testing revenue grew by 42%, driven …

NexPoint Residential Trust, Inc. Q2 2026: Revenue $64.6M, Net loss $(8.61M) — 10-Q Summary

NexPoint Residential Trust (NXRT) reported its Q2 2026 results, showing revenue of $64.6 million, a modest increase from $63.1 million in Q2 2025. However, the net loss attributable to common stockholders widened to $(8.61) million from $(7.03) million in the prior year. The company's …

PHR Stockholders Have Opportunity to Lead Phreesia, Inc. Class Ac

Bronstein, Gewirtz & Grossman, LLC has filed a class action lawsuit against Phreesia, Inc. (NYSE:PHR) and certain officers, alleging federal securities law violations. The lawsuit claims that Phreesia made false and misleading statements regarding slowing demand, diminished revenue visibility, and weakened pharmaceutical marketing commitments …

Quanome Technologies (QNME) adopts new name and ticker on Nasdaq

Quanome Technologies, formerly Lakeside Holding Limited, has officially changed its corporate name and stock ticker to QNME on The Nasdaq Capital Market. The name change, effective August 3, 2026, required no stockholder action as it solely involved a name alteration, and it does not …

Resideo Technologies Completes Spin-Off of ADI Global Distribution to Become Pure-Play Building Company

Resideo Technologies has completed the spin-off of its ADI Global Distribution business, creating two separate publicly traded companies: Resideo Technologies (REZI) and ADI (ADIG). This strategic move aims to provide both entities with a sharper focus and greater financial flexibility. Resideo is now a …

NexPoint Residential Trust Inc. (NXRT) Loses 15.6% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

NexPoint Residential Trust Inc. (NXRT) has seen a 15.6% decline in its stock price over the past four weeks. However, the stock is now in oversold territory with an RSI reading of 29.7, suggesting a potential trend reversal. Analysts also show strong agreement in …

Lakeside Holding Limited has Changed its Name to Quanome Technologies, Inc

Lakeside Holding Limited has officially changed its name to Quanome Technologies, Inc. The company, trading under the stock symbol QNME, is involved in the pharmaceutical sector, primarily as a medical injection and pharmaceutical distributor through its subsidiary Hupan Pharmaceutical (Hubei) Co., Ltd. This announcement …

NEXPOINT RESIDENTIAL TRUST, INC. REPORTS SECOND QUARTER 2026 RESULTS

NexPoint Residential Trust, Inc. (NXRT) reported its financial results for the second quarter and first six months of 2026. The company experienced a net loss of $8.6 million for Q2 2026 and $15.4 million year-to-date, with decreases in FFO, Core FFO, and AFFO compared …

Kilbourne Graphite Advances Towards Commercialization with Global Refractory Manufacturer

Titan Mining Corporation Conditional supply agreement signed with a leading global refractory manufacturer GOUVERNEUR, N.Y., Aug. 05, 2026 (GLOBE NEWSWIRE) -- Titan Mining Corporation (NYSE-A:TII, TSX:TI), ("Titan" or the "Company"), a U.S.-focused critical minerals producer and developer, today announced that RHI Magnesita ("RHI Magnesita" …

Uni-President China's Profit Climbs 9% in H1

Resideo Technologies (REZI) Earnings Expected to Grow: Should You Buy?

Resideo Technologies (REZI) is expected to report a year-over-year increase in earnings for the quarter ended June 2026, despite lower projected revenues. The company's Zacks Earnings ESP of +6.83% combined with a Zacks Rank #3 suggests a high probability of beating consensus EPS estimates. …

Designer Brands Inc. (DBI) EVP exercises RSUs, shares withheld

Laura Davis, EVP and President of DSW Designer Shoe Warehouse at Designer Brands Inc. (DBI), converted equity awards on August 1, 2026. This included 12,566 dividend equivalent rights and 101,935 restricted stock units into Class A common shares. To cover tax obligations, 34,547 shares …

Is Genesis Energy (ASX:GNE) a Utility Dividend Stock Worth Watching by Income Investors?

Biodesix (NASDAQ: BDSX) lifts lung test revenue and raises $23.9M equity

Uni-President China Holdings Ltd Reports Earnings Results for the Half Year Ended June 30, 2026

Biodesix (NASDAQ:BDSX) Announces Earnings Results

PT Bank Negara Indonesia (Persero) Tbk 2026 Q2 - Results - Earnings Call Presentation

This article first appeared on GuruFocus. Release Date: August 05, 2026 For the complete transcript of the earnings call, please refer to the full earnings call transcript. Positive Points PT Bank Negara Indonesia (Persero) Tbk (PTBRY) achieved its highest core profit (PPOP) in five …

ACES trails MDIY on margins despite similar revenue

Resideo Technologies (REZI) Projected to Announce Quarterly Earnings on Wednesday

Resideo Technologies (REZI) is expected to report its Q2 2026 earnings after market close on Wednesday, August 12th, with analysts forecasting earnings per share of $0.68 on $1.937 billion in revenue. This is slightly below the company's own guidance of $0.71-$0.75 EPS. REZI shares …

Equity Residential (EQR) Reports Mixed Earnings, Is The 7% Discount Enough?

Equity Residential (EQR) reported mixed second-quarter earnings with higher sales but declining net income and EPS. Despite a recent share price dip, the stock maintains positive year-to-date and one-year returns. Analysts project EQR to be 7.3% undervalued, with a fair value estimate of $73.06 …

QNME Stock Price and Chart — NASDAQ:QNME

This article provides a detailed overview of Quanome Technologies, Inc. (QNME) stock on NASDAQ, including its current price, historical performance, key financial metrics, and company details. It covers various aspects like market capitalization, revenue, employee data, and technical analysis indicators. The article also addresses …

Craig-Hallum Maintains Design Therapeutics(DSGN.US) With Buy Rating, Maintains Target Price $22

Craig-Hallum has reiterated its Buy rating for Design Therapeutics (DSGN.US) and maintained its target price at $22. This indicates a continued positive outlook from the firm regarding the company's stock performance.

Genesis Energy Earnings: What To Look For From GEL

Enterprise value to revenue forward of Cartesian Therapeutics, Inc. – MUN:1S70

The article focuses on the enterprise value to revenue forward metric for Cartesian Therapeutics, Inc. (MUN:1S70), listed on the Munich Stock Exchange. It provides financial overview, documents, news, community insights, forecasts, seasonals, and ETF information related to the company. The content appears to be …